...
首页> 外文期刊>Acta Neuropathologica >Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease
【24h】

Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease

机译:神经炎症损害阿尔茨海默氏病临床前模型中树突棘的适应性结构可塑性

获取原文
获取原文并翻译 | 示例
           

摘要

To successfully treat Alzheimer's disease (AD), pathophysiological events in preclinical stages need to be identified. Preclinical AD refers to the stages that exhibit amyloid deposition in the brain but have normal cognitive function, which are replicated in young adult APPswe/PS1deltaE9 (deltaE9) mice. By long-term in vivo two-photon microscopy, we demonstrate impaired adaptive spine plasticity in these transgenic mice illustrated by their failure to increase dendritic spine density and form novel neural connections when housed in enriched environment (EE). Decrease of amyloid plaques by reducing BACE1 activity restores the gain of spine density upon EE in deltaE9 mice, but not the remodeling of neural networks. On the other hand, anti-inflammatory treatment with pioglitazone or interleukin 1 receptor antagonist in deltaE9 mice successfully rescues the impairments in increasing spine density and remodeling of neural networks during EE. Our data suggest that neuroinflammation disrupts experience-dependent structural plasticity of dendritic spines in preclinical stages of AD.
机译:为了成功治疗阿尔茨海默氏病(AD),需要确定临床前阶段的病理生理事件。临床前AD是指在大脑中表现出淀粉样蛋白沉积但具有正常认知功能的阶段,这些阶段在年轻的成年APPswe / PS1deltaE9(deltaE9)小鼠中复制。通过长期的体内双光子显微镜,我们证明了这些转基因小鼠的适应性脊柱可塑性受损,这是由于它们无法增加树突状脊柱密度并在富集环境(EE)中居住时无法形成新的神经连接。通过减少BACE1活性减少淀粉样斑块可恢复DeltaE9小鼠在EE时的脊柱密度,但不能恢复神经网络的重塑。另一方面,在deltaE9小鼠中使用吡格列酮或白介素1受体拮抗剂进行抗炎治疗,成功地挽救了EE期间增加脊柱密度和神经网络重构的障碍。我们的数据表明,神经炎症会破坏AD临床前阶段依赖经验的树突棘的结构可塑性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号